Admire Dube (Mervin Meyer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Human Serum Albumin

High Efficiency

Top Venues

Health policy and planning

Pharmaceutical research

Pharmaceutical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Naasika Hamman, Poornima Ramburrun, Admire Dube
Selenium Nanoparticle Activity against S. mutans Biofilms as a Potential Treatment Alternative for Periodontitis. Pharmaceutics 16 (4) (2024)
Bakani Mark Ncube, Admire Dube, Kim Ward
The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies. Health policy and planning 39 (5) (2024)
Naasika Hamman, Poornima Ramburrun, Admire Dube
Selenium Nanoparticle Activity against S. mutans Biofilms as a Potential Treatment Alternative for Periodontitis. Pharmaceutics 16 (4) (2024)
Bakani Mark Ncube, Admire Dube, Kim Ward
The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies. Health policy and planning 39 (5) (2024)
Bakani Mark Ncube, Admire Dube, Kim Ward
The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies. Health policy and planning 39 (5) (2024)
Jeanri Myburgh, Wilna Liebenberg, Clarissa Willers, Admire Dube, Minja Gerber
Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems. Pharmaceutics 15 (10) (2023)
Estelle-Vionè Louw, Wilna Liebenberg, Clarissa Willers, Admire Dube, Marique E Aucamp, Minja Gerber
Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension. Drug delivery and translational research (2022)
Bakani Mark Ncube, Admire Dube, Kim Ward
Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency. Pharmaceutical medicine 36 (2) (2022)
Admire Dube, Samuel Ayodele Egieyeh, Mohammed Balogun
A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa. Viruses 13 (10) (2021)
Sinaye Mhambi, David Fisher, Moise B Tchoula Tchokonte, Admire Dube
Permeation Challenges of Drugs for Treatment of Neurological Tuberculosis and HIV and the Application of Magneto-Electric Nanoparticle Drug Delivery Systems. Pharmaceutics 13 (9) (2021)
Mookho S Lerata, Sarah D'Souza, Nicole R S Sibuyi, Nicole Remaliah Samantha Sibuyi, Admire Dube, Toufiek Samaai, Edith M Antunes, Denzil R Beukes
Encapsulation of Variabilin in Stearic Acid Solid Lipid Nanoparticles Enhances Its Anticancer Activity in Vitro. Molecules (Basel, Switzerland) 25 (4) (2020)
Lesego L Tshweu, Mohamed Abbas Shemis, Aya Abdelghany, Abdullah Gouda, Lynne Alison Pilcher, Nicole Remaliah Samantha Sibuyi, Mervin Meyer, Admire Dube, Mohammed O Balogun
Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin. RSC advances 10 (34) (2020)
Tendai Samkange, Sarah D'Souza, Kenechukwu Obikeze, Admire Dube
Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin. The Journal of pharmacy and pharmacology 71 (10) (2019)
Admire Dube
Nanomedicines for Infectious Diseases. Pharmaceutical research 36 (4) (2019)
Matshawandile Tukulula, Luis Gouveia, Paulo Paixao, Rose Hayeshi, Brendon Naicker, Admire Dube
Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages. Pharmaceutical research 35 (6) (2018)
Raymonde B Bekale, Su-Mari Du Plessis, Nai-Jen Hsu, Jyoti R Sharma, Samantha L Sampson, Muazzam Jacobs, Mervin Meyer, Gene D Morse, Admire Dube
Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines. Pharmaceutical research 36 (1) (2018)